Theriva Biologics, Inc. (TOVX)
USD 1.17
(-1.68%)
USD 1.17
(-1.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 135 Thousand | 268 Thousand | 87 Thousand | 201 Thousand | 240 Thousand | 272 Thousand |
| Gross Profit | -135 Thousand | -268 Thousand | -87 Thousand | -201 Thousand | -240 Thousand | -272 Thousand |
| Operating Expenses | 21.43 Million | 21.58 Million | 14.27 Million | 10.16 Million | 15.66 Million | 17.57 Million |
| Selling, General and Administrative Expenses | 7.78 Million | 9.85 Million | 6.47 Million | 5.02 Million | 4.58 Million | 5.72 Million |
| Research and Development Expenses | 14.31 Million | 11.72 Million | 7.8 Million | 5.13 Million | 11.08 Million | 11.84 Million |
| Other Expenses | -660 Thousand | - | - | - | - | - |
| Cost and Expenses | 21.43 Million | 21.58 Million | 14.27 Million | 10.16 Million | 15.66 Million | 17.57 Million |
| Operating Income | -21.43 Million | -21.58 Million | -14.27 Million | -10.16 Million | -15.66 Million | -17.57 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -1.64 Million | -1.42 Million | -94 Thousand | -117 Thousand | -360 Thousand | -4.2 Million |
| Earnings before Tax | -19.98 Million | -21.11 Million | -14.26 Million | -10.11 Million | -15.38 Million | -13.42 Million |
| Net Income | -18.34 Million | -19.68 Million | -14.17 Million | -9.99 Million | -15.02 Million | -13.36 Million |
| Earnings Per Share Basic | -28.49 | -32.11 | -1.16 | -5.26 | -9.14 | -21.45 |
| Earnings Per Share Diluted | -28.48 | -32.11 | -1.16 | -5.26 | -9.14 | -21.45 |
| Weighted Average Shares Outstanding | 644 Thousand | 613.09 Thousand | 12.18 Million | 1.9 Million | 1.64 Million | 623.24 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 644.28 Thousand | 613.09 Thousand | 12.18 Million | 1.9 Million | 1.64 Million | 623.24 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -19.85 Million | -21.58 Million | -14.18 Million | -9.95 Million | -15.42 Million | -17.29 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 758 Thousand | - | - |
| Cost of Revenue | 38 Thousand | 39 Thousand | 135 Thousand | 39 Thousand | 134 Thousand | 131 Thousand |
| Gross Profit | -38 Thousand | -39 Thousand | -135 Thousand | 719 Thousand | -134 Thousand | -131 Thousand |
| Operating Expenses | 4.38 Million | 5.35 Million | 21.95 Million | 5.83 Million | 4.21 Million | 5.82 Million |
| Selling, General and Administrative Expenses | 1.42 Million | 1.89 Million | - | 1.64 Million | 212 Thousand | 2.68 Million |
| Research and Development Expenses | 2.95 Million | 3.45 Million | - | 4.19 Million | 4 Million | 3.13 Million |
| Other Expenses | 3.79 Million | - | - | - | - | - |
| Cost and Expenses | 4.42 Million | 5.39 Million | 22.09 Million | 5.87 Million | 4.21 Million | 5.82 Million |
| Operating Income | -4.42 Million | -5.39 Million | -22.09 Million | -5.87 Million | -4.21 Million | -5.82 Million |
| Interest Expense | - | - | - | 408 Thousand | - | - |
| Income Tax Expense | - | -4276.00 | -1.64 Million | -424 Thousand | -527 Thousand | -359 Thousand |
| Earnings before Tax | -8.31 Million | -5.16 Million | -19.98 Million | -5.9 Million | -3.83 Million | -5.44 Million |
| Net Income | -8.31 Million | -5.16 Million | -18.34 Million | -5.48 Million | -3.3 Million | -5.08 Million |
| Earnings Per Share Basic | -10.72 | -7.53 | - | -8.00 | -4.85 | -8.38 |
| Earnings Per Share Diluted | -10.72 | -7.53 | - | -8.00 | -4.85 | -8.38 |
| Weighted Average Shares Outstanding | 775.73 Thousand | 685.9 Thousand | 644.28 Thousand | 685.92 Thousand | 681.71 Thousand | 606.65 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 775.73 Thousand | 685.9 Thousand | 644.28 Thousand | 685.92 Thousand | 681.71 Thousand | 606.65 Thousand |
| Gross Margin | - | - | - | 0.95 | - | - |
| EBIT Margin | - | - | - | -7.70 | - | - |
| Profit Margin | - | - | - | -7.24 | - | - |
| EBITDA | -4.38 Million | -5.35 Million | - | -5.83 Million | -4.21 Million | -5.78 Million |
| Earnings Before Tax Margin | - | - | - | -7.75 | - | - |
ORXOF
1233
SGSN
RWEOY
ELEEF
INRLF